Elizabeth M Azzato

Summary

Affiliation: University of Cambridge
Country: UK

Publications

  1. ncbi Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort
    Elizabeth M Azzato
    Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK
    Breast Cancer Res 10:R47. 2008
  2. ncbi Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk
    Karen A Pooley
    Cancer Research UK Genetic Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, United Kingdom
    Cancer Epidemiol Biomarkers Prev 17:3482-9. 2008
  3. ncbi SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
    Elizabeth M Azzato
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, Maryland, USA
    BMC Med Genet 10:9. 2009
  4. ncbi A genome-wide association study of prognosis in breast cancer
    Elizabeth M Azzato
    Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom
    Cancer Epidemiol Biomarkers Prev 19:1140-3. 2010
  5. ncbi Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer
    Miriam S Udler
    Strangeways Research Laboratory, Departments of Public Health and Primary Care and Oncology, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, United Kingdom
    Int J Cancer 125:2687-96. 2009
  6. ncbi Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations
    Elizabeth M Azzato
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, Maryland 20852, USA
    Pharmacogenet Genomics 20:58-63. 2010
  7. ncbi Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer
    Thibaud Koessler
    Department of Oncology, University of Cambridge, Cambridge, United Kingdom
    Int J Cancer 124:1887-91. 2009
  8. ncbi PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
    Gordon C Wishart
    Cambridge Breast Unit, Addenbrooke s Hospital, Hills Road, Cambridge, CB2 2QQ, UK
    Breast Cancer Res 12:R1. 2010

Detail Information

Publications8

  1. ncbi Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort
    Elizabeth M Azzato
    Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK
    Breast Cancer Res 10:R47. 2008
    ..Of particular interest are genes involved in cell cycle pathways, which regulate cell division...
  2. ncbi Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk
    Karen A Pooley
    Cancer Research UK Genetic Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, United Kingdom
    Cancer Epidemiol Biomarkers Prev 17:3482-9. 2008
    ..20; 95% CI, 1.07-1.36; P trend = 0.002). In summary, there was little evidence of breast cancer susceptibility with any of the SNPs studied, but larger studies would be needed to confirm subgroup effects...
  3. ncbi SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
    Elizabeth M Azzato
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, Maryland, USA
    BMC Med Genet 10:9. 2009
    ....
  4. ncbi A genome-wide association study of prognosis in breast cancer
    Elizabeth M Azzato
    Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom
    Cancer Epidemiol Biomarkers Prev 19:1140-3. 2010
    ..Traditional clinicopathologic features of breast cancer do not account for all the variation in survival. Germline genetic variation may provide additional prognostic information...
  5. ncbi Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer
    Miriam S Udler
    Strangeways Research Laboratory, Departments of Public Health and Primary Care and Oncology, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, United Kingdom
    Int J Cancer 125:2687-96. 2009
    ..These results suggest that COMT rs4818, or a variant it tags, is associated with breast cancer prognosis. Further study of COMT and its putative association with breast cancer prognosis is warranted...
  6. ncbi Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations
    Elizabeth M Azzato
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, Maryland 20852, USA
    Pharmacogenet Genomics 20:58-63. 2010
    ....
  7. ncbi Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer
    Thibaud Koessler
    Department of Oncology, University of Cambridge, Cambridge, United Kingdom
    Int J Cancer 124:1887-91. 2009
    ..59, 95% confidence interval (CI) 0.42-0.82, p-value: 0.001). In conclusion, we find some evidence that common variants in mismatch repair genes may contribute to survival of patients with colorectal cancer...
  8. ncbi PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
    Gordon C Wishart
    Cambridge Breast Unit, Addenbrooke s Hospital, Hills Road, Cambridge, CB2 2QQ, UK
    Breast Cancer Res 12:R1. 2010
    ..The aim of this study was to develop and validate a prognostication model to predict overall and breast cancer specific survival for women treated for early breast cancer in the UK...